Peyman, M. (2024). Study of new strategies for steatotic liver disease: SIRT1-mediated modulation of VLDLR levels and evaluation of a soluble epoxyde hydrolase-targeted PROTAC.
Citación estilo ChicagoPeyman, Mona. Study of New Strategies for Steatotic Liver Disease: SIRT1-mediated Modulation of VLDLR Levels and Evaluation of a Soluble Epoxyde Hydrolase-targeted PROTAC. 2024.
Cita MLAPeyman, Mona. Study of New Strategies for Steatotic Liver Disease: SIRT1-mediated Modulation of VLDLR Levels and Evaluation of a Soluble Epoxyde Hydrolase-targeted PROTAC. 2024.
Precaución: Estas citas no son 100% exactas.